Stroke prevention by percutaneous closure of patent foramen ovale: A systematic review and meta-analysis

Heart

Volumn 100, Issue 5, 2014, Pages 389-395

  Wolfrum, Mathias ^a   Froehlich, Georg M ^b   Knapp, Guido ^c   Casaubon, Leanne K ^d   DiNicolantonio, James J ^e   Lansky, Alexandra J ^f   Meier, Pascal ^b,f  

^a Spital Zollikerberg ^*  (Switzerland)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c TU DORTMUND UNIVERSITY   (Germany)

^d TORONTO WESTERN HOSPITAL   (Canada)

^e Wegmans Pharmacy   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT;

ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; HEART ATRIUM FIBRILLATION; HEART SURGERY; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; PATENT FORAMEN OVALE; PERCUTANEOUS PATENT FORAMEN OVALE CLOSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SECONDARY PREVENTION; SEPTAL OCCLUDER; SYSTEMATIC REVIEW; TRANSIENT ISCHEMIC ATTACK;

CARDIAC CATHETERIZATION; FORAMEN OVALE, PATENT; HUMANS; INCIDENCE; RISK ASSESSMENT; SECONDARY PREVENTION; SEPTAL OCCLUDER DEVICE; STROKE; SURVIVAL RATE; THROMBOLYTIC THERAPY; WORLD HEALTH;

EID: 84896690978     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2013-304394     Document Type: Article

References (36)

1. Koullias GJ, Elefteriades JA, Wu I, et al. Massive paradoxical embolism caught in the act. Circulation 2004;109:3056-7. (Pubitemid 38808329)
2. Fukumoto A, Yaku H, Doi K, et al. Continuous thrombus in the right and left atria penetrating the patent foramen ovalis. Circulation 2005;112:e143-4.
3. Pavoni D, Zanuttini D, Spedicato L, et al. Large interatrial thrombus-in-transit resulting in acute myocardial infarction complicated by atrioventricular block and cardiogenic shock. J Am Coll Cardiol 2012;59:1329.
4. Fraticelli A, Gambini C, Iannoni E, et al. Impending paradoxical embolism through a patent foramen ovale in an octogenarian with pulmonary embolism: detection by transesophageal echocardiography and successful treatment by anticoagulation. Arch Gerontol Geriatr 1998;27:41-7. (Pubitemid 28401016)
5. Casaubon L, McLaughlin P, Webb G, et al. Recurrent stroke/TIA in cryptogenic stroke patients with patent foramen ovale. Can J Neurol Sci 2007;34:74-80. (Pubitemid 46423346)
6. Wahl A, Juni P, Mono ML, et al. Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism. Circulation 2012;125:803-12.
7. Meier B, Kalesan B, Mattle HP, et al. Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med 2013;368:1083-91.
8. Furlan AJ, Reisman M, Massaro J, et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med 2012;366:991-9.
9. Higgins JPT, Green Se. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. http:// www.cochrane-handbook.org
10. Juni P, Witschi A, Bloch R, et al. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999;282:1054-60. (Pubitemid 29436453)
11. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88. (Pubitemid 17189972)
12. Higgins JP, Thompson SG, Spiegelhalter DJ. A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc 2009;172:137-59.
13. Sankey SS, Weissfeld LA, Fine MJ, et al. An assessment of the use of the continuity correction for sparse data in meta-analysis. Commun Stat Simul C 1996;25:1031-56. (Pubitemid 126434250)
14. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-58. (Pubitemid 34746062)
15. Follmann DA, Proschan MA. Valid inference in random effects meta-analysis. Biometrics 1999;55:732-7. (Pubitemid 29427071)
16. Knapp G, Hartung J. Improved tests for a random effects meta-regression with a single covariate. Stat Med 2003;22:2693-710. (Pubitemid 37038351)
17. Miller JJ. The inverse of the Freeman-Tukey double arcsine transformation. Am Stat 1978;32:138.
18. Team RDC. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing. Vienna, Austria 2013 (www.Rproject. org).
19. Carroll JD, Saver JL, Thaler DE, et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med 2013; 368:1092-100.
20. Paciaroni M, Agnelli G, Bertolini A, et al. Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study. Cerebrovasc Dis 2011;31:109-16.
21. Faggiano P, Frattini S, Piovesana P, et al. Low cerebrovascular event rate in subjects with patent foramen ovale and different clinical presentations: results from a prospective non randomized study on a population including patients with and without patent foramen ovale closure. Int J Cardiol 2012;156:47-52.
22. Mazzucco S, Bovi P, Carletti M, et al. A model of multi-disciplinary approach to the diagnosis and treatment of young patients with cryptogenic stroke and patent foramen ovale. Cardiol Young 2012;22:327-34.
23. Horner S, Niederkorn K, Gattringer T, et al. Management of right-to-left shunt in cryptogenic cerebrovascular disease: results from the observational Austrian paradoxical cerebral embolism trial (TACET) registry. J Neurol 2013; 260:260-7.
24. Schuchlenz HW, Weihs W, Berghold A, et al. Secondary prevention after cryptogenic cerebrovascular events in patients with patent foramen ovale. Int J Cardiol 2005;101:77-82. (Pubitemid 40614739)
25. Harrer JU, Wessels T, Franke A, et al. Stroke recurrence and its prevention in patients with patent foramen ovale. Can J Neurol Sci 2006;33:39-47.
26. Thanopoulos BV, Dardas PD, Karanasios E, et al. Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke. Catheter Cardiovasc Interv 2006;68:741-6. (Pubitemid 44721098)
27. Cerrato P, Priano L, Imperiale D, et al. Recurrent cerebrovascular ischaemic events in patients with interatrial septal abnormalities: a follow-up study. Neurol Sci 2006;26:411-18.
28. Lee JY, Song JK, Song JM, et al. Association between anatomic features of atrial septal abnormalities obtained by omni-plane transesophageal echocardiography and stroke recurrence in cryptogenic stroke patients with patent foramen ovale. Am J Cardiol 2010;106:129-34.
29. Agarwal S, Bajaj NS, Kumbhani DJ, et al. Meta-analysis of transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism. JACC Cardiovasc Interv 2012;5:777-89.
30. Sorensen HT, Horvath-Puho E, Pedersen L, et al. Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study. Lancet 2007;370:1773-9. (Pubitemid 350137491)
31. Lansberg MG, O'Donnell MJ, Khatri P, et al. Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th edn: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141:e601S-36S.
32. Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011;42:227-76.
33. Lamy C, Giannesini C, Zuber M, et al. Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA Study. Atrial Septal Aneurysm. Stroke 2002;33:706-11. (Pubitemid 34203994)
34. Homma S, Sacco RL, Di Tullio MR, et al. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation 2002;105:2625-31. (Pubitemid 34596039)
35. Pezzini A, Grassi M, Lodigiani C, et al. Interaction between proatherosclerotic factors and right-to-left shunt on the risk of cryptogenic stroke: the Italian Project on Stroke in Young Adults. Heart 2012;98:485-9.
36. Dahabreh IJ, Kent DM. Towards an epidemiology of the known unknowns in cryptogenic stroke. Heart 2012;98:1114-16.